Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.874,44
-1,51%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ RayzeBio Inc (RYZB) RayzeBio Inc (RYZB) Notizie

RayzeBio Inc

RYZB
62,49
0,00 (0,00%)
15 Lug 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202422:07EDGAR2Form 15-12G - Securities registration termination [Section..
27/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:20EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/2/202415:20EDGAR2Form 8-K - Current report
23/2/202413:53EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23/2/202412:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
14/2/202415:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/2/202414:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/2/202412:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/2/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202414:53EDGAR2Form SC 14D9 - Solicitation, recommendation statements
08/1/202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
27/12/202322:15EDGAR2Form SC14D9C - Written communication relating to third party..
26/12/202323:08EDGAR2Form SC14D9C - Written communication relating to third party..
26/12/202316:28DJNTrending: Bristol Myers Squibb to Buy RayzeBio
26/12/202314:32EDGAR2Form SC14D9C - Written communication relating to third party..
26/12/202314:26EDGAR2Form 8-K - Current report
26/12/202314:04DJNRayzeBio Shares Soar Premarket on Takeover by Bristol Myers
26/12/202313:46DJNBristol Myers Squibb to Buy RayzeBio for $4.1 Billion
26/12/202313:13GLOBEBristol Myers Squibb Adds Premier Radiopharmaceutical..
26/12/202312:59BW Bristol Myers Squibb Adds Premier Radiopharmaceutical..
18/11/202300:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:03EDGAR2Form 8-K - Current report
13/11/202322:01GLOBERayzeBio Reports Third Quarter 2023 Financial Results and..
06/11/202322:05GLOBERayzeBio to Participate in Upcoming Investor Conferences in..
01/11/202314:14EDGAR2Form 8-K - Current report
01/11/202311:00GLOBERayzeBio Appoints Industry Leader Tim Van Hauwermeiren to..
24/10/202314:00GLOBEFDA selects RayzeBio to Participate in the Inaugural CDRP..
18/10/202313:00GLOBERayzeBio to Present at European Society for Medical Oncology..
19/9/202322:01BWRayzeBio, Inc. Announces Closing of Upsized $358 Million..
Apertura: Min: Max:
Chiusura: 62,49

La tua Cronologia

NASDAQ
RYZB
RayzeBio
KOSDAQ
049180
Cellumed
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network